Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents-Reference-Cited by-同舟云学术

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents

Published:2022-10 Issue:5 Volume:20 Page:e396-e405
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Spees Lisa P.^ORCID,Dinan Michaela A.,Jackson Bradford E.,Baggett Christopher D.,Wilson Lauren E.,Greiner Melissa A.,Kaye Deborah R.,Zhang Tian,George Daniel J.,Scales Charles D.,Pritchard Jessica E.,Leapman Michael,Gross Cary P.,Wheeler Stephanie B.

Funder

National Institutes of Health

National Cancer Institute

University of North Carolina

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference44 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations;Lindskog;Urol Oncol Semin Orig Investig,2017

3. Effect of incidental detection for survival of patients with renal cell carcinoma: Results of population-based study of 701 patients;Gudbjartsson;Urology,2005

4. Epidemiology of renal cell carcinoma;Capitanio;Eur Urol,2019

5. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis;Scoll;J Urol,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special populations in metastatic renal cell carcinoma;Current Opinion in Oncology;2024-02-23